
OncoRes Medical
An imaging technology to provide intraoperative information available to surgeons.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | AUD1.0m | Grant | |
Total Funding | 000k |
Related Content
OncoRes Medical is a medical device company focused on developing an intraoperative imaging system to assist surgeons in the complete removal of cancerous tissue during surgery. The core technology provides real-time assessment of tissue microstructure at a microscopic level, enabling surgeons to more accurately identify and excise tumors.
This system is designed to address the significant issue of incomplete cancer removal in procedures like breast-conserving surgery, which often leads to the need for costly and psychologically taxing repeat operations. By offering a tool for the intraoperative assessment of tumor margins, the company aims to improve patient outcomes and reduce healthcare system expenditures. The business model centers on the development and sale of this medical device to hospitals and surgical centers. The primary clients are surgeons and healthcare providers involved in oncology.
Keywords: intraoperative imaging, medical device, cancer surgery, tissue assessment, surgical oncology, medtech, tumor margins, breast-conserving surgery, real-time diagnostics, surgical guidance